Sharp increase in use of prescription sleep aids by young adults
“Reinstatement of drug-seeking behavior after an extended period of abstinence is the number-one cause of drug-addiction relapse,” said Brookhaven neuroanatomist Stephen Dewey, who led the research team. “This animal study suggests that vigabatrin could potentially prevent human methamphetamine addicts from relapsing.” According to the National Institute on Drug Abuse, methamphetamine is a very addictive stimulant
Full Post: Hope for treating relapse to methamphetamine abuse
Use of prescription sleep aids nearly tripled among 18- to 24-year-olds between 1998 and 2006, according to a study released today by the Healthcare business of Thomson Reuters.
During the study period, the average length of time sleep aids were used by adults under age 45 increased more than 40 percent — rising from 64 days in 1998 to 93 days in 2006.
“Insomnia, a condition traditionally associated with older adults, appears to be causing larger numbers of young adults to turn to prescription sleep aids, and to depend on them for longer periods of time,” said William Marder, PhD, senior vice president and general manager for the Healthcare business of Thomson Reuters.
The study is based on medical and drug claims data from the Thomson Reuters MarketScan(R) Research Databases. Results were weighted to reflect the U.S. population with employer-sponsored health insurance.
Researchers found a 50-percent increase in the use of prescription sleep aids among all adults under age 45 from 1998 to 2006. The most dramatic increase was seen in the youngest segment of the study population, those between the ages of 18 and 24, whose prevalence of use increased from 599 users per 100,000 in 1998 to 1,524 users per 100,000 in 2006. For those 25 to 34 years of age, use almost doubled from 1,372 users to 2,528 users per 100,000.
Non-benzodiazepine hypnotics — such as Ambien CR and Lunesta — accounted for almost two-thirds of all the prescription sleep aids used by this population.
A number of psychiatric, cognitive and conditioning factors are known to perpetuate insomnia, and the study found that 25 percent of first-time sleep aid users had a mental heath diagnosis in the month prior to sleep aid use. However, fewer than 10 percent of these new users visited a mental health professional prior to initiating sleep aid use. Most prescriptions were provided by family-practice physicians, acute care hospitals and doctors specializing in internal medicine and obstetrics/gynecology.
A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment. The study estimates that the total annual cost of insomnia in the province of Quebec is 6.5 billion Canadian dollars, representing about one percent of
Full Post: Social and economic burden of insomnia is high
Research in the current issue of the Journal of Clinical Sleep Medicine shows that after a one-hour delay of school start times, teens increased their average nightly hours of sleep and decreased their “catch-up sleep” on the weekends, and they were involved in fewer auto accidents. When school started one hour later students averaged
Full Post: Later school start times may improve sleep in teens and decrease risk of auto accidents
The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research’s Seventh Annual International Conference on Frontiers in Cancer Prevention Research. Compared with the general population, the risk for non-AIDS cancers was 2.3 times higher for
Full Post: Risk of non-AIDS cancer higher for individuals infected with HIV
A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope. Results of this study confirmed a relationship between frequent
Full Post: Respiratory sinus arrhythmia is a significant predictor of insomnia in women with breast cancer
An experimental drug developed by Australian scientists could offer a new cure for jet lag and be a welcome alternative to addictive sedatives such as benzodiazepines. The scientists from Monash University’s School of Psychology, Psychiatry and Psychological Medicine led by Dr. Shantha Rajaratnam, say the new drug Tasimelteon works by shifting the natural ebb and
Full Post: New sleeping pill could be the answer to jet lag